Pharmaceutical preparations company · DE · FY ends Dec · Revenue $217M · -102.93% margin · -$278M FCF
The business is unprofitable at the operating level (-158.45% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 627.8% YoY with margins expanding 1276.0pp.
Negative free cash flow of -$323M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$217M
▲ +627.8% YoY
Net Income (TTM)
-$243M
▲ +10.5% YoY
Op. Margin
-102.93%
▲ +1276.0pp YoY
ROIC
-40.61%
▲ +4.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$278M
▼ -17.6% YoY
Op. Cash Flow (TTM)
-$278M
▼ -17.5% YoY
Net Debt
-$2M
Net Cash Position
Cash & Equiv.
$352M
5Y CAGR: +157.7%
Continue Research